Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Ovarian serous cystadenocarcinoma (OV) is a fatal gynecologic cancer with a five-year survival rate of only 46%. Resistance to platinum-based chemotherapy is a prevalent factor in OV patients, leading to increased mortality. The platinum resistance in OV is driven by transcriptome heterogeneity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Zhang, Weiwei, Qiu, Jinxin, Zhang, Weiling, Lu, Mengmeng, Wang, Jiaqian, Jin, Yunfeng, Xi, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164874/
https://www.ncbi.nlm.nih.gov/pubmed/37168445
http://dx.doi.org/10.1155/2023/4500561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164874/
https://www.ncbi.nlm.nih.gov/pubmed/37168445
http://dx.doi.org/10.1155/2023/4500561

Ejemplares similares